Plant ID: NPO16027
Plant Latin Name: Niphogeton ternata
Taxonomy Genus: Niphogeton
Taxonomy Family: Apiaceae
NCBI TaxonomyDB:
681593
Plant-of-the-World-Online:
n.a.
MAPK1; | |
NR1H4; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Cytochrome P450 family 2 | CYP2A13 | Cytochrome P450 2A13 | Q16696 | CHEMBL3542436 |
Cytochrome P450 family 2 | CYP2D6 | Cytochrome P450 2D6 | P10635 | CHEMBL289 |
Cytochrome P450 family 2 | CYP2A6 | Cytochrome P450 2A6 | P11509 | CHEMBL5282 |
Cytochrome P450 family 2 | CYP2C19 | Cytochrome P450 2C19 | P33261 | CHEMBL3622 |
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Nuclear hormone receptor subfamily 1 group H | NR1H4 | Bile acid receptor FXR | Q96RI1 | CHEMBL2047 |
Protein Kinase | MAPK1 | MAP kinase ERK2 | P28482 | CHEMBL4040 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 1.810E-13 | 1.971E-09 | CYP1A2, CYP2C19, CYP2D6, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0008395; steroid hydroxylase activity | 6.931E-13 | 3.773E-09 | CYP2A13, CYP2A6, CYP2C19, CYP2D6, CYP3A4 |
MF | GO:0005488; binding | GO:0020037; heme binding | 2.084E-12 | 9.076E-09 | CYP1A2, CYP2A13, CYP2A6, CYP2C19, CYP2D6, CYP3A4 |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 3.039E-12 | 1.026E-08 | CYP1A2, CYP2A13, CYP2C19, CYP2D6, CYP3A4 |
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 5.968E-12 | 1.607E-08 | CYP1A2, CYP2A6, CYP2C19, CYP3A4 |
MF | GO:0005488; binding | GO:0005506; iron ion binding | 8.120E-12 | 1.607E-08 | CYP1A2, CYP2A13, CYP2A6, CYP2C19, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0019373; epoxygenase P450 pathway | 7.205E-11 | 1.307E-07 | CYP1A2, CYP2A13, CYP2A6, CYP2C19 |
BP | GO:0008152; metabolic process | GO:0008202; steroid metabolic process | 1.128E-10 | 1.754E-07 | CYP1A2, CYP2A6, CYP2C19, CYP2D6, CYP3A4, NR1H4 |
MF | GO:0003824; catalytic activity | GO:0070330; aromatase activity | 1.066E-10 | 1.754E-07 | CYP1A2, CYP2A13, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0006805; xenobiotic metabolic process | 3.619E-10 | 4.148E-07 | CYP1A2, CYP2A13, CYP2C19, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0009804; coumarin metabolic process | 1.631E-09 | 1.614E-06 | CYP2A13, CYP2A6, CYP2D6 |
BP | GO:0008152; metabolic process | GO:0070989; oxidative demethylation | 1.024E-08 | 7.964E-06 | CYP1A2, CYP2D6, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0008392; arachidonic acid epoxygenase activity | 3.162E-08 | 2.152E-05 | CYP2A13, CYP2A6, CYP2C19 |
MF | GO:0003824; catalytic activity | GO:0008389; coumarin 7-hydroxylase activity | 1.501E-07 | 8.833E-05 | CYP2A13, CYP2A6 |
CC | GO:0016020; membrane | GO:0005789; endoplasmic reticulum membrane | 2.982E-07 | 1.623E-04 | CYP1A2, CYP2A13, CYP2A6, CYP2C19, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0009822; alkaloid catabolic process | 4.502E-07 | 2.228E-04 | CYP2D6, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0034875; caffeine oxidase activity | 9.002E-07 | 4.171E-04 | CYP1A2, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 6.743E-06 | 2.879E-03 | CYP1A2, CYP2C19 |
CC | GO:0016020; membrane | GO:0031090; organelle membrane | 1.667E-04 | 5.763E-02 | CYP1A2, CYP2A13, CYP2A6, CYP2C19, CYP2D6, CYP3A4 |
CC | Unclassified; | GO:0031143; pseudopodium | 7.020E-03 | 7.962E-01 | MAPK1 |
CC | GO:0044464; cell part | GO:0035578; azurophil granule lumen | 3.708E-02 | 1.000E+00 | MAPK1 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 2.342E-11 | 1.533E-09 | CYP2A6, CYP2D6, CYP1A2, CYP3A4, CYP2C19 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 3.129E-11 | 1.533E-09 | CYP2A6, CYP2A13, CYP2D6, CYP1A2, CYP3A4 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 5.678E-11 | 1.855E-09 | CYP2A6, CYP2A13, CYP1A2, CYP3A4, CYP2C19 |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 1.527E-07 | 3.742E-06 | CYP1A2, CYP3A4, CYP2C19 |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 1.814E-06 | 2.962E-05 | CYP2A6, CYP1A2, CYP3A4 |
09150 Organismal Systems | 09156 Nervous system | hsa04726 | Serotonergic synapse | 9.380E-06 | 1.313E-04 | CYP2D6, MAPK1, CYP2C19 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00983 | Drug metabolism - other enzymes | 1.436E-04 | 1.760E-03 | CYP2A6, CYP3A4 |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 8.386E-04 | 7.471E-03 | CYP2A6, CYP1A2, CYP2C19, CYP3A4 |
09100 Metabolism | 09103 Lipid metabolism | hsa00140 | Steroid hormone biosynthesis | 2.289E-04 | 2.492E-03 | CYP1A2, CYP3A4 |
09150 Organismal Systems | 09154 Digestive system | hsa04976 | Bile secretion | 3.431E-04 | 3.363E-03 | NR1H4, CYP3A4 |
09100 Metabolism | 09110 Biosynthesis of other secondary metabolites | hsa00232 | Caffeine metabolism | 1.399E-06 | 2.742E-05 | CYP2A6, CYP1A2 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|